SlideShare a Scribd company logo
1 of 16
Download to read offline
Hester Bioscience Ltd
(BSE Code: 524669)
Presentatio by: Tejas Jariwala
Jainam Wealth
Date: 25-03-2017
Vote of thanks!
Let me all thank…
Ø Jainam Wealth Research Team - Mr.Vardhan Gandhi
Ø Pioneers in Value Investing..
Ø Fellow value investors..
Ø Managements of companies we invest in...
AND THANK YOU
FOR COMING!!!
ü Global animal healthcare market was valued at USD 32,081.5 mn
(~Rs.208530 Cr) in 2014 and is expected to rise to USD 43,032.1 mn
(~Rs.280000 Cr) by 2020 at a CAGR of 5.1 %.
ü Increasing adoption of pets in emerging economies such as India and China
are driving pet vaccinations in emerging economies and increasing the global
demand for meat, milk and eggs, steadily pushing feed additives,
pharmaceuticals and vaccine sales around the world.
ü Demand is expected to increase in the emerging markets of India, Indonesia,
Thailand, Vietnam, Brazil Argentina, Chile, Israel, CIS countries Ukraine,
Russia, South Africa and China.
Industry Overview - Global Veterinary Market
ü The Indian veterinary healthcare market was estimated at Rs.6800 Cr in 2014
and expected to reach Rs.15900 by 2020, reporting a CAGR of 15.2 per cent.
ü Though the market size of animal health products worldwide is approximately
Rs.156000 Cr (as of 2014), currently the Indian size is just Rs.3270 Cr but it is
growing at a very fast pace so offers a good scope for the future.
ü Per capita chicken consumption in India has been on the rise. At present, urban
markets account for about 80% of demand but rural demand is expected to pick
up.
ü The PPR vaccine is to be administered annually to a target population. The
targeted global sheep and goat population for PPR vaccine is 1.70 billion; the
targeted Indian population is 200 million.
Industry Overview - Indian Veterinary Market
About Company
ü Hester Biosciences Ltd is engaged in the manufacturing of Poultry Vaccines.
The company is a 100% biotech company producing animal biologicals. They
currently manufacture 39 types of poultry vaccines against various poultry
diseases.
ü Product range includes Live Vaccines, Killed Vaccines, Diagnostic kits &
Seromonitoring services.
ü The 4 verticals: Poultry Vaccines, Large Animal Vaccines, Poultry Health Products
and Large Animal Health Products.
ü Company’s product portfolio comprises of over 50 vaccines and over 35 health
products.
ü Hester is the 2nd largest producer of poultry vaccines in India with a market
share of 28-30 % (1st is Venky's)
ü 87 % of the revenues are derived from the poultry vaccines segment. This segment
grew at a CAGR of 20% over FY 2011 to FY 2015 and the Company expects the
segment to grow at a CAGR of 16% over FY 2015-18.
ü Company manufactures both strain of PPR vaccines (Goat & Sheeps) .i.e.
Nigerian and Sungari (Indian)
Hester Biosciences Ltd
About Company
ü 1st to launch Goat vaccines in India.
ü Launched new Brucella vaccine which is both in tender business & private
distribution & marketing so is expected to drive growth in large animal
vaccine segment.
ü For Brucella vaccine size of Indian market is 15-20 Cr they are second private
manufacturer in India
ü Hester’s Nepal plant will manufacture and export PPR vaccines. Commercial
operations have been commenced from Nov 15, 2016
ü They have 2 vaccine to bid internationally one PPR from Nepal and other
Brucella vaccine from India.
ü To bolster its distribution capabilities in Africa, Hester registered a Company
named ‘Leruarua Vetcare (Proprietary) Limited’ under the trade name of
Vetsol in Botswana with 49% stake.
ü Leruarua Vetcare (Proprietary) Limited is in the business of trading for the
Poultry Vaccines and Large Animal Vaccines & Health Products
ü The Company’s current international presence spans over 18 countries
ü Company intends to acquire 55% stake of Texas laboratories (located at
Mehsana) who is manufacturer of pharma formulation, tablets, capsules,
injections. (Animal related)
Hester Biosciences Ltd
Rationale..(Growth Drivers)
ü India has the largest cattle population in the world. It accounts for 31.05 %
of the world cattle population with an estimated 301,600,000 units of in
May 2016. This presents a massive opportunity for the animal healthcare
market.
ü Poultry has a crucial place in India as the eggs and chicken meat are
important and rich sources of protein, vitamins and minerals. Many Indian
families, especially the educated people in urban areas, have begun to
accept eggs as a regular supplemental part of their vegetarian diet.
ü The annual per capita consumption of poultry in India (in 2015) was merely
3.1 kg compared with 17 kg in developed countries.
ü Company’s large animal business revenue grew by 73.23 % (Newly started
division in 2015). It's export earnings 73.66 %, which reduced its
dependence on the domestic market.
ü The targeted global sheep and goat population for PPR vaccine is Rs.170 Cr;
the targeted Indian population is Rs.20 Cr.
ü The price of PPR vaccine as high as 10 US cents (Rs 6 per dose) while the
company’s selling price in India is approximately around 2.5 to 3.5 cents
(around Rs.2 per dose)
What we like.....
Rationale..(Growth Drivers)
ü The world market for PPR vaccine is slated to be for Rs.300 Cr.annually. The
Indian market is slated to be Rs.40Cr annually. Hester is looking to
aggressively market PPR and goat pox vaccines in India.
ü Hester is pursuing R&D to manufacture recombinant poultry vaccines, which
Hester expects to patent in about 2 years. Hester believes that is the only
Indian company right now working on a Recombinant Poultry Vaccines.
ü Recombinant vaccine would command premium price and would have
higher margins compared to conventional vaccines.
ü CARE has upgraded credit ratings (Long Term credit facility BBB+ to A-) &
(Short Term credit facility A3+ to A2) of the company so company will get
benefit of interest leverage in coming quarters.
ü Goat pox and Brucella vaccines are not imported in India. Neither Indian
Immunologicals are supplying got pox and Brucella in India.
ü Brucella (Cattle Vaccines)has good market internationally, which is more
than PPR vaccine, but for first 6-8 months they will only focus in India and
then will go to African market.
What we like.....
Hester’s Strength Cold Storage and Distribution
ü The distribution network is an important aspect as vaccines generally need
to be stored between 4 to 8 degrees Celsius, and some required to be stored
at minus 196 degrees Celsius.
ü The Company has established a strong, multi locational cold chain for the
distribution and storage of vaccines. Most of the places in African countries
have hot climate, are very remote and lack widespread refrigeration. Thus,
storage points and transportation network are critical for the success of
vaccines business.
ü The company has put a lot of focus on the African market for distribution
and thus has appointed distribution agents/centres in various countries
mainly in Southern part of Africa as well as Eastern Africa.
What we like.....
Entry Barriers
ü Vaccine R&D and large scale manufacturing is a niche business with tall
entry barriers. Vaccines are biological i.e. made from living microorganism,
unlike many medicines that are chemically synthesized.
ü Biologics manufacturing technology is complex and very difficult to replicate,
which is why there are only a handful of manufactures in India - Venky’s,
Indian Immunologicals, and Indovax are the only major manufacturers
besides Hester.
ü Also availability of strain in order to make vaccines is another issue.
ü Another major barrier is the cold storage depots and distribution network,
which forms the backbone of this business. Hester has its own depots in
Chandigarh, Pune, Bengaluru, Coimbatore and Hyderabad.
ü All Vaccines are transported by Hester-owned refrigerated vans under 4-8
degree Celsius. Cold storage and distribution is capital-intensive and is most
efficient when owned by the company itself.
ü Others --submitted 92 dosseries, patent likely in the coming years
ü Increasing focus on export revenues (presently ~10% of total revenue)
What we like.....
Financial Highlights..
Financial Highlights..
Risk
ü Contagious viral Diseases - and other flue which adversly affect the business
whereby poultry owner has to destroy live stocks.
ü Competition because of high entry barrier, nich business and good margins.
It may easy for large pharma conglomerate to focus this kinda business.
ü Managements are over promised and delayed delivered. :)
ü Any mismanagement in storage and distribution may lead to expiry of
vaccines.
ü Our limited understanding on the diseases, vaccines types , any scientific
terms and its proper knoweldge --”Black Swan”
Pending Works for further due diligence:
ü To study sequent Scientific in detail (Demerger-Human and Animal health
division)
ü AGM / Plant Visit / Management meet
What can go wrong..
ü Final View:
At the CMP of Rs. 753, the stock is trading at TTM PE of 33x with the TTM EPS of
Rs.22.20. We believe, Hester is good placed in the poultry vaccines business
which is niche in the overall Pharma categeries. Nepal Plant set up, Goat
vaccines, tendering of PPR and Brucella vaccines, strong distribution channels
globally- appeals to have this company in the portfolio. :)
Disclosure: Holding tracking position in the personal portfolio. So, obviously
biasness may be there.:)
We, Jainam Wealth, a partnership firm is registerd with SEBI- Research Analyst
Regulation,2014. Our Registration Number is: INH000003218
Final View & Valuation:
Q & A

More Related Content

Similar to Hester bio final 25_march2017

Dr Yongsheng Wang, General Manager, Jinyu Biopharmaceuticals
Dr Yongsheng Wang, General Manager, Jinyu BiopharmaceuticalsDr Yongsheng Wang, General Manager, Jinyu Biopharmaceuticals
Dr Yongsheng Wang, General Manager, Jinyu BiopharmaceuticalsKisaco Research
 
Why Processed Chicken is just 5% of the Poultry Market.
Why Processed Chicken is just 5% of the Poultry Market. Why Processed Chicken is just 5% of the Poultry Market.
Why Processed Chicken is just 5% of the Poultry Market. P.Rajan Mathews
 
Agritech_ENG 2023.pdf
Agritech_ENG 2023.pdfAgritech_ENG 2023.pdf
Agritech_ENG 2023.pdfBoalvet AI
 
A study on sales and promotion startegies towards Excellent Biotechnologies
A study on sales and promotion startegies towards Excellent Biotechnologies A study on sales and promotion startegies towards Excellent Biotechnologies
A study on sales and promotion startegies towards Excellent Biotechnologies Muneer Mohammed
 
Indonesia animal feed additive,indonesia animal anti oxidants industry
Indonesia animal feed additive,indonesia animal anti oxidants industryIndonesia animal feed additive,indonesia animal anti oxidants industry
Indonesia animal feed additive,indonesia animal anti oxidants industryKen Research Pvt ltd.
 
Livestock insurance lessons from the indian experience
Livestock insurance lessons from the indian experienceLivestock insurance lessons from the indian experience
Livestock insurance lessons from the indian experienceCIRM
 
Cattle & poultry feed manufacturing business 252054-
Cattle & poultry feed manufacturing business 252054-Cattle & poultry feed manufacturing business 252054-
Cattle & poultry feed manufacturing business 252054-PRATAP MISHRA
 
Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...
Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...
Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...IMARC Group
 
GAVL Fertilizer.pptx
GAVL Fertilizer.pptxGAVL Fertilizer.pptx
GAVL Fertilizer.pptxMANAK KUMAR
 
Indian Pharma Market Overview -2018
Indian Pharma Market Overview -2018Indian Pharma Market Overview -2018
Indian Pharma Market Overview -2018Nitesh Bhele
 
Salvare Business Plan.pdf final
Salvare Business Plan.pdf finalSalvare Business Plan.pdf final
Salvare Business Plan.pdf finalMike Ficocelli
 
Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...
Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...
Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...IMARC Group
 

Similar to Hester bio final 25_march2017 (20)

internship report
internship reportinternship report
internship report
 
Dr Yongsheng Wang, General Manager, Jinyu Biopharmaceuticals
Dr Yongsheng Wang, General Manager, Jinyu BiopharmaceuticalsDr Yongsheng Wang, General Manager, Jinyu Biopharmaceuticals
Dr Yongsheng Wang, General Manager, Jinyu Biopharmaceuticals
 
Why Processed Chicken is just 5% of the Poultry Market.
Why Processed Chicken is just 5% of the Poultry Market. Why Processed Chicken is just 5% of the Poultry Market.
Why Processed Chicken is just 5% of the Poultry Market.
 
Equity Project
Equity ProjectEquity Project
Equity Project
 
Equity project
Equity projectEquity project
Equity project
 
Agritech_ENG 2023.pdf
Agritech_ENG 2023.pdfAgritech_ENG 2023.pdf
Agritech_ENG 2023.pdf
 
A study on sales and promotion startegies towards Excellent Biotechnologies
A study on sales and promotion startegies towards Excellent Biotechnologies A study on sales and promotion startegies towards Excellent Biotechnologies
A study on sales and promotion startegies towards Excellent Biotechnologies
 
Indonesia animal feed additive,indonesia animal anti oxidants industry
Indonesia animal feed additive,indonesia animal anti oxidants industryIndonesia animal feed additive,indonesia animal anti oxidants industry
Indonesia animal feed additive,indonesia animal anti oxidants industry
 
Livestock insurance lessons from the indian experience
Livestock insurance lessons from the indian experienceLivestock insurance lessons from the indian experience
Livestock insurance lessons from the indian experience
 
Cattle & poultry feed manufacturing business 252054-
Cattle & poultry feed manufacturing business 252054-Cattle & poultry feed manufacturing business 252054-
Cattle & poultry feed manufacturing business 252054-
 
Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...
Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...
Indonesia Animal Feed Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...
 
Think Grain Think Feed December 2020
Think Grain Think Feed December 2020Think Grain Think Feed December 2020
Think Grain Think Feed December 2020
 
Project report / Pre-feasibility report on dairy farming
Project report / Pre-feasibility report on dairy farmingProject report / Pre-feasibility report on dairy farming
Project report / Pre-feasibility report on dairy farming
 
GAVL Fertilizer.pptx
GAVL Fertilizer.pptxGAVL Fertilizer.pptx
GAVL Fertilizer.pptx
 
HF Corporate India
HF Corporate IndiaHF Corporate India
HF Corporate India
 
Indian Pharma Market Overview -2018
Indian Pharma Market Overview -2018Indian Pharma Market Overview -2018
Indian Pharma Market Overview -2018
 
Salvare Business Plan.pdf final
Salvare Business Plan.pdf finalSalvare Business Plan.pdf final
Salvare Business Plan.pdf final
 
Novartis india
Novartis indiaNovartis india
Novartis india
 
Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...
Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...
Poultry Feed Market Growth, Demand and Challenges of the Key Industry Players...
 
H & Care Incorp - PCD Pharma Franchise
H & Care Incorp - PCD Pharma FranchiseH & Care Incorp - PCD Pharma Franchise
H & Care Incorp - PCD Pharma Franchise
 

More from tdjariwala

Greenply industries
Greenply industriesGreenply industries
Greenply industriestdjariwala
 
Indian Energy Exchange Ltd report
Indian Energy Exchange Ltd reportIndian Energy Exchange Ltd report
Indian Energy Exchange Ltd reporttdjariwala
 
Narayan hrudyalaya
Narayan hrudyalayaNarayan hrudyalaya
Narayan hrudyalayatdjariwala
 
Balrampur chini
Balrampur chiniBalrampur chini
Balrampur chinitdjariwala
 
Vbl annual update 2017
Vbl annual update 2017Vbl annual update 2017
Vbl annual update 2017tdjariwala
 
Tyre sector and Companies report
Tyre sector and Companies reportTyre sector and Companies report
Tyre sector and Companies reporttdjariwala
 
Varun Beverages Ltd
Varun Beverages LtdVarun Beverages Ltd
Varun Beverages Ltdtdjariwala
 
Birla corporation limited
Birla corporation limitedBirla corporation limited
Birla corporation limitedtdjariwala
 

More from tdjariwala (14)

Bandhan
BandhanBandhan
Bandhan
 
Mahindra CIE
Mahindra CIEMahindra CIE
Mahindra CIE
 
Accelya kale
Accelya kaleAccelya kale
Accelya kale
 
Greenply industries
Greenply industriesGreenply industries
Greenply industries
 
Indian Energy Exchange Ltd report
Indian Energy Exchange Ltd reportIndian Energy Exchange Ltd report
Indian Energy Exchange Ltd report
 
Narayan hrudyalaya
Narayan hrudyalayaNarayan hrudyalaya
Narayan hrudyalaya
 
Kcp ltd
Kcp ltdKcp ltd
Kcp ltd
 
Bse ltd
Bse ltdBse ltd
Bse ltd
 
Tci Express
Tci ExpressTci Express
Tci Express
 
Balrampur chini
Balrampur chiniBalrampur chini
Balrampur chini
 
Vbl annual update 2017
Vbl annual update 2017Vbl annual update 2017
Vbl annual update 2017
 
Tyre sector and Companies report
Tyre sector and Companies reportTyre sector and Companies report
Tyre sector and Companies report
 
Varun Beverages Ltd
Varun Beverages LtdVarun Beverages Ltd
Varun Beverages Ltd
 
Birla corporation limited
Birla corporation limitedBirla corporation limited
Birla corporation limited
 

Recently uploaded

Prezentacja Q1 2024 EN strona www relacji
Prezentacja Q1 2024  EN strona www relacjiPrezentacja Q1 2024  EN strona www relacji
Prezentacja Q1 2024 EN strona www relacjiklaudiafilka
 
Economic Risk Factor Update: May 2024 [SlideShare]
Economic Risk Factor Update: May 2024 [SlideShare]Economic Risk Factor Update: May 2024 [SlideShare]
Economic Risk Factor Update: May 2024 [SlideShare]Commonwealth
 
NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...
NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...
NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...Amil baba
 
原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作
原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作
原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作uotyyd
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...israjan914
 
一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书
一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书
一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书atedyxc
 
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书atedyxc
 
DSP Gold ETF Fund of Fund PPT - April'2024
DSP Gold ETF Fund of Fund PPT - April'2024DSP Gold ETF Fund of Fund PPT - April'2024
DSP Gold ETF Fund of Fund PPT - April'2024DSP Mutual Fund
 
L1 2024 Prequisite QM persion milad1371.pdf
L1 2024 Prequisite QM persion milad1371.pdfL1 2024 Prequisite QM persion milad1371.pdf
L1 2024 Prequisite QM persion milad1371.pdfmiladsojoudi211
 
certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...israjan914
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...israjan914
 
project ratio analysis of bcom studies .
project ratio analysis of bcom studies .project ratio analysis of bcom studies .
project ratio analysis of bcom studies .borndark09
 
Retail sector trends for 2024 | European Business Review
Retail sector trends for 2024  | European Business ReviewRetail sector trends for 2024  | European Business Review
Retail sector trends for 2024 | European Business ReviewAntonis Zairis
 
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书atedyxc
 
Slideshare - ONS Economic Forum Slidepack - 13 May 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 13 May 2024.pptxSlideshare - ONS Economic Forum Slidepack - 13 May 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 13 May 2024.pptxOffice for National Statistics
 
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdfAdnet Communications
 
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书atedyxc
 
Financial Accounting and Analysis balancesheet.pdf
Financial Accounting and Analysis balancesheet.pdfFinancial Accounting and Analysis balancesheet.pdf
Financial Accounting and Analysis balancesheet.pdfmukul381940
 

Recently uploaded (20)

Prezentacja Q1 2024 EN strona www relacji
Prezentacja Q1 2024  EN strona www relacjiPrezentacja Q1 2024  EN strona www relacji
Prezentacja Q1 2024 EN strona www relacji
 
Economic Risk Factor Update: May 2024 [SlideShare]
Economic Risk Factor Update: May 2024 [SlideShare]Economic Risk Factor Update: May 2024 [SlideShare]
Economic Risk Factor Update: May 2024 [SlideShare]
 
SAUDI ARABIYA | +966572737505 |Jeddah Get Cytotec pills for Abortion pills
SAUDI ARABIYA | +966572737505 |Jeddah Get Cytotec pills for Abortion pillsSAUDI ARABIYA | +966572737505 |Jeddah Get Cytotec pills for Abortion pills
SAUDI ARABIYA | +966572737505 |Jeddah Get Cytotec pills for Abortion pills
 
NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...
NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...
NO1 Top Vashikaran Specialist in Uk Black Magic Specialist in Uk Black Magic ...
 
原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作
原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作
原版一模一样(bu文凭证书)美国贝翰文大学毕业证文凭证书制作
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...
 
一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书
一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书
一比一原版(BU毕业证书)波士顿大学毕业证成绩单学位证书
 
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
一比一原版(UC Davis毕业证书)加州大学戴维斯分校毕业证成绩单学位证书
 
DSP Gold ETF Fund of Fund PPT - April'2024
DSP Gold ETF Fund of Fund PPT - April'2024DSP Gold ETF Fund of Fund PPT - April'2024
DSP Gold ETF Fund of Fund PPT - April'2024
 
L1 2024 Prequisite QM persion milad1371.pdf
L1 2024 Prequisite QM persion milad1371.pdfL1 2024 Prequisite QM persion milad1371.pdf
L1 2024 Prequisite QM persion milad1371.pdf
 
certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...certified amil baba ,black magic specialist in russia and kala jadu expert in...
certified amil baba ,black magic specialist in russia and kala jadu expert in...
 
amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...amil baba in australia amil baba in canada amil baba in london amil baba in g...
amil baba in australia amil baba in canada amil baba in london amil baba in g...
 
project ratio analysis of bcom studies .
project ratio analysis of bcom studies .project ratio analysis of bcom studies .
project ratio analysis of bcom studies .
 
Retail sector trends for 2024 | European Business Review
Retail sector trends for 2024  | European Business ReviewRetail sector trends for 2024  | European Business Review
Retail sector trends for 2024 | European Business Review
 
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
一比一原版(WashU毕业证书)圣路易斯华盛顿大学毕业证成绩单学位证书
 
Slideshare - ONS Economic Forum Slidepack - 13 May 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 13 May 2024.pptxSlideshare - ONS Economic Forum Slidepack - 13 May 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 13 May 2024.pptx
 
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
 
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
一比一原版(Caltech毕业证书)加利福尼亚理工学院毕业证成绩单学位证书
 
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRYDIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
 
Financial Accounting and Analysis balancesheet.pdf
Financial Accounting and Analysis balancesheet.pdfFinancial Accounting and Analysis balancesheet.pdf
Financial Accounting and Analysis balancesheet.pdf
 

Hester bio final 25_march2017

  • 1. Hester Bioscience Ltd (BSE Code: 524669) Presentatio by: Tejas Jariwala Jainam Wealth Date: 25-03-2017
  • 2. Vote of thanks! Let me all thank… Ø Jainam Wealth Research Team - Mr.Vardhan Gandhi Ø Pioneers in Value Investing.. Ø Fellow value investors.. Ø Managements of companies we invest in... AND THANK YOU FOR COMING!!!
  • 3. ü Global animal healthcare market was valued at USD 32,081.5 mn (~Rs.208530 Cr) in 2014 and is expected to rise to USD 43,032.1 mn (~Rs.280000 Cr) by 2020 at a CAGR of 5.1 %. ü Increasing adoption of pets in emerging economies such as India and China are driving pet vaccinations in emerging economies and increasing the global demand for meat, milk and eggs, steadily pushing feed additives, pharmaceuticals and vaccine sales around the world. ü Demand is expected to increase in the emerging markets of India, Indonesia, Thailand, Vietnam, Brazil Argentina, Chile, Israel, CIS countries Ukraine, Russia, South Africa and China. Industry Overview - Global Veterinary Market
  • 4. ü The Indian veterinary healthcare market was estimated at Rs.6800 Cr in 2014 and expected to reach Rs.15900 by 2020, reporting a CAGR of 15.2 per cent. ü Though the market size of animal health products worldwide is approximately Rs.156000 Cr (as of 2014), currently the Indian size is just Rs.3270 Cr but it is growing at a very fast pace so offers a good scope for the future. ü Per capita chicken consumption in India has been on the rise. At present, urban markets account for about 80% of demand but rural demand is expected to pick up. ü The PPR vaccine is to be administered annually to a target population. The targeted global sheep and goat population for PPR vaccine is 1.70 billion; the targeted Indian population is 200 million. Industry Overview - Indian Veterinary Market
  • 5. About Company ü Hester Biosciences Ltd is engaged in the manufacturing of Poultry Vaccines. The company is a 100% biotech company producing animal biologicals. They currently manufacture 39 types of poultry vaccines against various poultry diseases. ü Product range includes Live Vaccines, Killed Vaccines, Diagnostic kits & Seromonitoring services. ü The 4 verticals: Poultry Vaccines, Large Animal Vaccines, Poultry Health Products and Large Animal Health Products. ü Company’s product portfolio comprises of over 50 vaccines and over 35 health products. ü Hester is the 2nd largest producer of poultry vaccines in India with a market share of 28-30 % (1st is Venky's) ü 87 % of the revenues are derived from the poultry vaccines segment. This segment grew at a CAGR of 20% over FY 2011 to FY 2015 and the Company expects the segment to grow at a CAGR of 16% over FY 2015-18. ü Company manufactures both strain of PPR vaccines (Goat & Sheeps) .i.e. Nigerian and Sungari (Indian) Hester Biosciences Ltd
  • 6. About Company ü 1st to launch Goat vaccines in India. ü Launched new Brucella vaccine which is both in tender business & private distribution & marketing so is expected to drive growth in large animal vaccine segment. ü For Brucella vaccine size of Indian market is 15-20 Cr they are second private manufacturer in India ü Hester’s Nepal plant will manufacture and export PPR vaccines. Commercial operations have been commenced from Nov 15, 2016 ü They have 2 vaccine to bid internationally one PPR from Nepal and other Brucella vaccine from India. ü To bolster its distribution capabilities in Africa, Hester registered a Company named ‘Leruarua Vetcare (Proprietary) Limited’ under the trade name of Vetsol in Botswana with 49% stake. ü Leruarua Vetcare (Proprietary) Limited is in the business of trading for the Poultry Vaccines and Large Animal Vaccines & Health Products ü The Company’s current international presence spans over 18 countries ü Company intends to acquire 55% stake of Texas laboratories (located at Mehsana) who is manufacturer of pharma formulation, tablets, capsules, injections. (Animal related) Hester Biosciences Ltd
  • 7.
  • 8. Rationale..(Growth Drivers) ü India has the largest cattle population in the world. It accounts for 31.05 % of the world cattle population with an estimated 301,600,000 units of in May 2016. This presents a massive opportunity for the animal healthcare market. ü Poultry has a crucial place in India as the eggs and chicken meat are important and rich sources of protein, vitamins and minerals. Many Indian families, especially the educated people in urban areas, have begun to accept eggs as a regular supplemental part of their vegetarian diet. ü The annual per capita consumption of poultry in India (in 2015) was merely 3.1 kg compared with 17 kg in developed countries. ü Company’s large animal business revenue grew by 73.23 % (Newly started division in 2015). It's export earnings 73.66 %, which reduced its dependence on the domestic market. ü The targeted global sheep and goat population for PPR vaccine is Rs.170 Cr; the targeted Indian population is Rs.20 Cr. ü The price of PPR vaccine as high as 10 US cents (Rs 6 per dose) while the company’s selling price in India is approximately around 2.5 to 3.5 cents (around Rs.2 per dose) What we like.....
  • 9. Rationale..(Growth Drivers) ü The world market for PPR vaccine is slated to be for Rs.300 Cr.annually. The Indian market is slated to be Rs.40Cr annually. Hester is looking to aggressively market PPR and goat pox vaccines in India. ü Hester is pursuing R&D to manufacture recombinant poultry vaccines, which Hester expects to patent in about 2 years. Hester believes that is the only Indian company right now working on a Recombinant Poultry Vaccines. ü Recombinant vaccine would command premium price and would have higher margins compared to conventional vaccines. ü CARE has upgraded credit ratings (Long Term credit facility BBB+ to A-) & (Short Term credit facility A3+ to A2) of the company so company will get benefit of interest leverage in coming quarters. ü Goat pox and Brucella vaccines are not imported in India. Neither Indian Immunologicals are supplying got pox and Brucella in India. ü Brucella (Cattle Vaccines)has good market internationally, which is more than PPR vaccine, but for first 6-8 months they will only focus in India and then will go to African market. What we like.....
  • 10. Hester’s Strength Cold Storage and Distribution ü The distribution network is an important aspect as vaccines generally need to be stored between 4 to 8 degrees Celsius, and some required to be stored at minus 196 degrees Celsius. ü The Company has established a strong, multi locational cold chain for the distribution and storage of vaccines. Most of the places in African countries have hot climate, are very remote and lack widespread refrigeration. Thus, storage points and transportation network are critical for the success of vaccines business. ü The company has put a lot of focus on the African market for distribution and thus has appointed distribution agents/centres in various countries mainly in Southern part of Africa as well as Eastern Africa. What we like.....
  • 11. Entry Barriers ü Vaccine R&D and large scale manufacturing is a niche business with tall entry barriers. Vaccines are biological i.e. made from living microorganism, unlike many medicines that are chemically synthesized. ü Biologics manufacturing technology is complex and very difficult to replicate, which is why there are only a handful of manufactures in India - Venky’s, Indian Immunologicals, and Indovax are the only major manufacturers besides Hester. ü Also availability of strain in order to make vaccines is another issue. ü Another major barrier is the cold storage depots and distribution network, which forms the backbone of this business. Hester has its own depots in Chandigarh, Pune, Bengaluru, Coimbatore and Hyderabad. ü All Vaccines are transported by Hester-owned refrigerated vans under 4-8 degree Celsius. Cold storage and distribution is capital-intensive and is most efficient when owned by the company itself. ü Others --submitted 92 dosseries, patent likely in the coming years ü Increasing focus on export revenues (presently ~10% of total revenue) What we like.....
  • 14. Risk ü Contagious viral Diseases - and other flue which adversly affect the business whereby poultry owner has to destroy live stocks. ü Competition because of high entry barrier, nich business and good margins. It may easy for large pharma conglomerate to focus this kinda business. ü Managements are over promised and delayed delivered. :) ü Any mismanagement in storage and distribution may lead to expiry of vaccines. ü Our limited understanding on the diseases, vaccines types , any scientific terms and its proper knoweldge --”Black Swan” Pending Works for further due diligence: ü To study sequent Scientific in detail (Demerger-Human and Animal health division) ü AGM / Plant Visit / Management meet What can go wrong..
  • 15. ü Final View: At the CMP of Rs. 753, the stock is trading at TTM PE of 33x with the TTM EPS of Rs.22.20. We believe, Hester is good placed in the poultry vaccines business which is niche in the overall Pharma categeries. Nepal Plant set up, Goat vaccines, tendering of PPR and Brucella vaccines, strong distribution channels globally- appeals to have this company in the portfolio. :) Disclosure: Holding tracking position in the personal portfolio. So, obviously biasness may be there.:) We, Jainam Wealth, a partnership firm is registerd with SEBI- Research Analyst Regulation,2014. Our Registration Number is: INH000003218 Final View & Valuation:
  • 16. Q & A